Details.
Provides prescription cost-sharing assistance for eligible privately insured clients. Annual assistance is up to $13,000 for Cabenuva, $7,500 for Triumeq, Triumeq PD, and Rukobia, $6,250 for Dovato and Juluca, $5,000 for Tivicay and Tivicay PD, and $4,800 for Lexiva, Selzentry, Ziagen, Trizivir, and Viracept. Cabenuva assistance also includes up to $100 per treatment for provider administration copays.